# Agios Pharmaceuticals Inc. (AGIO) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$472M |
| 2024 | -$426M |
| 2023 | -$391M |
| 2022 | -$389M |
| 2021 | -$378M |
| 2020 | -$336M |
| 2019 | -$316M |
| 2018 | -$362M |
| 2017 | -$321M |
| 2016 | -$201M |
| 2015 | -$119M |
| 2014 | -$54M |
| 2013 | -$39M |
| 2012 | -$23M |
| 2011 | -$17M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$110M |
| 2025-09-30 | -$117M |
| 2025-06-30 | -$127M |
| 2025-03-31 | -$107M |
| 2024-09-30 | -$103M |
| 2024-06-30 | -$106M |
| 2024-03-31 | -$92M |
| 2023-09-30 | -$101M |
| 2023-06-30 | -$94M |
| 2023-03-31 | -$91M |
| 2022-09-30 | -$91M |
| 2022-06-30 | -$98M |
| 2022-03-31 | -$101M |
| 2021-09-30 | -$91M |
| 2021-06-30 | -$91M |
| 2021-03-31 | -$91M |
| 2020-09-30 | -$80M |
| 2020-06-30 | -$83M |
| 2020-03-31 | -$87M |
| 2019-09-30 | -$109M |
| 2019-06-30 | -$114M |
| 2019-03-31 | -$97M |
| 2018-09-30 | -$99M |
| 2018-06-30 | -$73M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AGIO/operating-income)